Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125498331 | 12549833 | 1 | I | 200804 | 20160623 | 20160712 | 20160712 | EXP | US-DSJP-DSU-2016-121508 | DAIICHI | 0.00 | Y | 0.00000 | 20160712 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125498331 | 12549833 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | Y | 21286 | 40 | MG | TABLET | QD | |||||
| 125498331 | 12549833 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 20 MG, QD | Y | 21286 | 20 | MG | TABLET | QD | ||||||
| 125498331 | 12549833 | 3 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | UNK | Y | 21286 | TABLET | |||||||||
| 125498331 | 12549833 | 4 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/12.5MG, UNK | U | 0 | 1 | DF | FILM-COATED TABLET | |||||||
| 125498331 | 12549833 | 5 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/12.5 MG, UNK | U | 0 | 1 | DF | FILM-COATED TABLET | |||||||
| 125498331 | 12549833 | 6 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | UNK | U | 0 | FILM-COATED TABLET | |||||||||
| 125498331 | 12549833 | 7 | SS | STATIN /00848101/ | SIMVASTATIN | 1 | UNK | 0 | |||||||||||
| 125498331 | 12549833 | 8 | C | PRAVASTATIN. | PRAVASTATIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125498331 | 12549833 | 1 | Hypertension |
| 125498331 | 12549833 | 4 | Hypertension |
| 125498331 | 12549833 | 7 | Product used for unknown indication |
| 125498331 | 12549833 | 8 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125498331 | 12549833 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125498331 | 12549833 | Dehydration | |
| 125498331 | 12549833 | Diverticulum | |
| 125498331 | 12549833 | Drug-induced liver injury | |
| 125498331 | 12549833 | Haemorrhoids | |
| 125498331 | 12549833 | Hiatus hernia | |
| 125498331 | 12549833 | Hypokalaemia | |
| 125498331 | 12549833 | Hypomagnesaemia | |
| 125498331 | 12549833 | Hypophosphataemia | |
| 125498331 | 12549833 | Jaundice | |
| 125498331 | 12549833 | Lactic acidosis | |
| 125498331 | 12549833 | Malabsorption | |
| 125498331 | 12549833 | Malnutrition | |
| 125498331 | 12549833 | Pancreatitis | |
| 125498331 | 12549833 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125498331 | 12549833 | 1 | 20030313 | 20040129 | 0 | |
| 125498331 | 12549833 | 2 | 20030313 | 20040129 | 0 | |
| 125498331 | 12549833 | 3 | 201303 | 0 | ||
| 125498331 | 12549833 | 4 | 20040412 | 20041007 | 0 | |
| 125498331 | 12549833 | 5 | 20080410 | 0 | ||
| 125498331 | 12549833 | 6 | 201303 | 0 |